These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26489733)

  • 21. Dendritic cells from bench to bedside and back.
    Adema GJ
    Immunol Lett; 2009 Feb; 122(2):128-30. PubMed ID: 19121337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting human dendritic cell subsets for improved vaccines.
    Ueno H; Klechevsky E; Schmitt N; Ni L; Flamar AL; Zurawski S; Zurawski G; Palucka K; Banchereau J; Oh S
    Semin Immunol; 2011 Feb; 23(1):21-7. PubMed ID: 21277223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells.
    Unger WW; van Kooyk Y
    Curr Opin Immunol; 2011 Feb; 23(1):131-7. PubMed ID: 21169001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination with liposomal poly(I:C) induces discordant maturation of migratory dendritic cell subsets and anti-viral gene signatures in afferent lymph cells.
    Neeland MR; Elhay MJ; Meeusen EN; de Veer MJ
    Vaccine; 2014 Oct; 32(47):6183-92. PubMed ID: 25280435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Harnessing human dendritic cell subsets for medicine.
    Ueno H; Schmitt N; Klechevsky E; Pedroza-Gonzalez A; Matsui T; Zurawski G; Oh S; Fay J; Pascual V; Banchereau J; Palucka K
    Immunol Rev; 2010 Mar; 234(1):199-212. PubMed ID: 20193020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies for recruiting and targeting dendritic cells for optimizing HIV vaccines.
    Ahlers JD; Belyakov IM
    Trends Mol Med; 2009 Jun; 15(6):263-74. PubMed ID: 19487159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting dendritic cells--why bother?
    Kreutz M; Tacken PJ; Figdor CG
    Blood; 2013 Apr; 121(15):2836-44. PubMed ID: 23390195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Dendritic Cell Subsets Through Gene Expression Analysis.
    Vu Manh TP; Dalod M
    Methods Mol Biol; 2016; 1423():211-43. PubMed ID: 27142020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New generation of dendritic cell vaccines.
    Radford KJ; Caminschi I
    Hum Vaccin Immunother; 2013 Feb; 9(2):259-64. PubMed ID: 23291951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting human dendritic cells in situ to improve vaccines.
    Sehgal K; Dhodapkar KM; Dhodapkar MV
    Immunol Lett; 2014 Nov; 162(1 Pt A):59-67. PubMed ID: 25072116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells as a conduit to improve HIV vaccines.
    Pope M
    Curr Mol Med; 2003 May; 3(3):229-42. PubMed ID: 12699360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph node targeting strategies to improve vaccination efficacy.
    Jiang H; Wang Q; Sun X
    J Control Release; 2017 Dec; 267():47-56. PubMed ID: 28818619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting dendritic cells for improved HIV-1 vaccines.
    Smed-Sörensen A; Loré K
    Adv Exp Med Biol; 2013; 762():263-88. PubMed ID: 22975879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incorporation of CpG into a liposomal vaccine formulation increases the maturation of antigen-loaded dendritic cells and monocytes to improve local and systemic immunity.
    Neeland MR; Elhay MJ; Nathanielsz J; Meeusen EN; de Veer MJ
    J Immunol; 2014 Apr; 192(8):3666-75. PubMed ID: 24646740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells.
    Didierlaurent AM; Collignon C; Bourguignon P; Wouters S; Fierens K; Fochesato M; Dendouga N; Langlet C; Malissen B; Lambrecht BN; Garçon N; Van Mechelen M; Morel S
    J Immunol; 2014 Aug; 193(4):1920-30. PubMed ID: 25024381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen delivery by dendritic cells.
    Moll H
    Int J Med Microbiol; 2004 Oct; 294(5):337-44. PubMed ID: 15532992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease.
    Sakuraba A; Sato T; Kamada N; Kitazume M; Sugita A; Hibi T
    Gastroenterology; 2009 Nov; 137(5):1736-45. PubMed ID: 19632232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node.
    Dawicki W; Jawdat DW; Xu N; Marshall JS
    J Immunol; 2010 Feb; 184(4):2116-23. PubMed ID: 20083654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo dendritic cell generation-A critical comparison of current approaches.
    Han P; Hanlon D; Sobolev O; Chaudhury R; Edelson RL
    Int Rev Cell Mol Biol; 2019; 349():251-307. PubMed ID: 31759433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.
    van Kooyk Y; Unger WW; Fehres CM; Kalay H; García-Vallejo JJ
    Mol Immunol; 2013 Sep; 55(2):143-5. PubMed ID: 23158834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.